Richard Norman

Richard Norman is a Professor in the Curtin School of Population Health at Curtin University, serving as Dean of the Graduate Research School and a member of the Pharmaceutical Benefits Advisory Committee (PBAC) and its Economics Sub-Committee. He holds a BA(Hons) in Philosophy and Economics and an MSc in Health Economics from the University of York, UK, and a PhD from the University of Technology Sydney. His research focuses on health economics, including economic evaluation of healthcare, quality of life measurement, and discrete choice experiments. Norman has received prestigious awards, including the Australian Health Economics Society Rising Star Award (2021) and Curtin Mid-Career Researcher of the Year (2022).

His work spans global health economics, with contributions to utility valuation protocols for instruments like EQ-5D-5L and EORTC QLU-C10D. Norman leads projects funded by the NHMRC and ARC, emphasizing cost-effectiveness analysis and health policy. Notable collaborations include studies on familial hypercholesterolemia screening and telehealth preferences in Australia. His interdisciplinary approach integrates econometric analysis with large datasets to inform healthcare decisions.

• Employment History: NHMRC Early Career Fellow (2014-2018), Senior Research Fellow at UTS (2013-2014), and roles at Queen Mary College, London.
• Memberships: Australian Health Economics Society, ISPOR, EuroQol Group.
• Recent Grants: NHMRC and ARC-funded studies on utility valuation, telehealth, and chronic disease screening.

Publications highlight his expertise in discrete choice experiments, health state valuation, and policy-relevant research. Norman’s work bridges academic rigor with practical healthcare solutions, influencing both clinical and public health strategies.